z-logo
open-access-imgOpen Access
SAT-091 Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms
Author(s) -
Manali Sapre,
Douglas Tremblay,
Amanda Leiter,
Alexander Coltoff,
Anita Geevarghese,
John Mascarhenas,
Emily J. Gallagher
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sat-091
Subject(s) - ruxolitinib , medicine , myelofibrosis , clinical trial , oncology , bone marrow

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom